Chengyi Pharmaceutical: Dopamine Hydrochloride Injection Passes the Consistency Evaluation of Generic Drugs.

Chengyi Pharmaceuticals announced that the hydrochloride dobutamine injection produced by the company has passed the generic drug quality and efficacy consistency evaluation. This drug is mainly used for heart failure caused by a decrease in myocardial contractility in organic heart disease, including low cardiac output syndrome after cardiac surgery, as a short-term supportive therapy. As of the disclosure date of the announcement, there are a total of 31 manufacturers of hydrochloride dobutamine injection that have passed the consistency evaluation by the National Medical Products Administration.